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Abstract
Background: The increasing number of patients co-affected with Diabetes and TB may place individuals with low
socio-economic status at particular risk of persistent poverty. Kyrgyz health sector reforms aim at reducing this
burden, with the provision of essential health services free at the point of use through a State-Guaranteed Benefit
Package (SGBP). However, despite a declining trend in out-of-pocket expenditure, there is still a considerable
funding gap in the SGBP. Using data from Bishkek, Kyrgyzstan, this study aims to explore how households cope
with the economic burden of Diabetes, TB and co-prevalence.
Methods: This study uses cross-sectional data collected in 2010 from Diabetes and TB patients in Bishkek,
Kyrgyzstan. Quantitative questionnaires were administered to 309 individuals capturing information on patients’
socioeconomic status and a range of coping strategies. Coarsened exact matching (CEM) is used to generate socio-
economically balanced patient groups. Descriptive statistics and logistic regression are used for data analysis.
Results: TB patients are much younger than Diabetes and co-affected patients. Old age affects not only the health
of the patients, but also the patient’s socio-economic context. TB patients are more likely to be employed and to
have higher incomes while Diabetes patients are more likely to be retired. Co-affected patients, despite being in
the same age group as Diabetes patients, are less likely to receive pensions but often earn income in informal
arrangements. Out-of-pocket (OOP) payments are higher for Diabetes care than for TB care. Diabetes patients cope
with the economic burden by using social welfare support. TB patients are most often in a position to draw on
income or savings. Co-affected patients are less likely to receive social welfare support than Diabetes patients.
Catastrophic health spending is more likely in Diabetes and co-affected patients than in TB patients.
Conclusions: This study shows that while OOP are moderate for TB affected patients, there are severe
consequences for Diabetes affected patients. As a result of the underfunding of the SGBP, Diabetes and co-affected
patients are challenged by OOP. Especially those who belong to lower socio-economic groups are challenged in
coping with the economic burden.
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Co-prevalence
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Background
When confronted with long term illness, households face
not only a physical and mental burden, but also an eco-
nomic burden. The economic burden of illness commonly
includes the direct costs of treatment, drugs, transport
and fees and informal payments, and the indirect costs of
a reduction in their ability to generate income [1]. High
levels of health spending can exceed a household’s cap-
acity to pay, sometimes resulting in the sale of assets or
the incurring of debt. Health spending exceeding a certain
threshold of a household’s ability to pay is referred to in
the literature as catastrophic expenditure and this is
frequently the precursor to the medical poverty trap [2].
There is substantial evidence that health systems financed
with out of pocket payments (OOP), are more likely to
cause catastrophic health expenditure and resulting pov-
erty, particularly in low- and middle-income countries
(LMICs) [2–4].
To meet the financial costs of ill health, households may
use a range of coping strategies such as selling household
assets, reallocating spending from consumption and invest-
ment, borrowing money or working extra hours [5–7]. For
tuberculosis (TB) care, the most commonly reported strat-
egies are borrowing money, selling assets, using savings
and transfers from relatives [8]. While such strategies can
help to cope with the immediate economic burden [9],
they can also leave the household at risk of long-term pov-
erty [10]. Coping strategies are often categorised into detri-
mental strategies i.e. borrowing money or selling livelihood
assets, and non-detrimental strategies, i.e. income or sav-
ings, labour substitution or social networks [6, 11, 12]. Det-
rimental coping strategies draw on the households’ ability
to generate future income or leave the household indebted
and thus at higher risk of economic vulnerability and pov-
erty in the long run [10, 11, 13–16]. Empirical research has
shown that detrimental coping strategies are more likely to
be used by households with lower income and higher
health expenditure [11, 17].
TB is a major public health threat in many LMICs and
its control and prevention are priorities for many
national and international health authorities, and non-
governmental organisations [18]. Diabetes and TB have
strong co-morbidities, with both the incidence and severity
of TB being affected by Diabetes [19–22]. The rising preva-
lence of Diabetes in many LMICs thus poses an increasing
risk for the control and prevention of TB [23–25]. As
such, while this case study is focused on a single city
in a LMIC with a developing health care system, the
findings may have relevance for other countries in the
process of developing their health care system.
Kyrgyzstan is a former Soviet Republic in Central Asia.
It is a lower-middle income country with a Gross National
Income per capita of $880 in 2010 [26]. In Kyrgyzstan,
the Diabetes prevalence rate among the population
aged 20 to 79 years, is at 6.3 % [27] and TB prevalence
was estimated at 190 per 100,000 in 2013 [28].
Kyrgyzstan is one of the 18 high-priority countries in
the Stop TB Plan of the WHO region [29] and one of
the 27 countries with high rates of multidrug-resistant
tuberculosis (MDR-TB) [30].
TB medicine and treatment is based on Direct
Observed Treatment Short course (DOTS) and DOTS
plus programs for the treatment of MDR-TB. DOTS is
available throughout Kyrgyzstan, but DOTS plus is lim-
ited to some areas of Kyrgyzstan. Medicines for DOTS
and DOTS plus programs are supplied mainly through
the Global Fund and government funds. Patients do not
pay for TB medicines, but for other supporting medi-
cines and treatments e.g. vitamins, which are not pro-
vided for free. Financial barriers may also exist with
regards to paying for transportation for outpatient man-
agement of TB and from first to secondary care facility
when patients are referred. While some local authorities
do reimburse for transport cost, this is not the standard
for all health facilities. Similar challenges were also
found for people with Diabetes in a previous study by
Abdraimova, Beran [31]. In addition, poor purchasing
practices were found in the management of Diabetes, re-
sulted in Diabetic patients needing to purchase some or
all of their diagnostic and therapeutic appliances and
medicines in private sector [32].
In recent years, Kyrgyzstan has undergone major struc-
tural reforms in the health sector, improving the provision
of universal health care. In 1996, the national health care
reform programme, called Manas, was adopted, which had
the improvement of access to health care as one of its pil-
lars [33]. In 2002, a State-Guaranteed Benefit Package
(SGBP) was introduced providing a list of basic health ser-
vices free at the point of use [33, 34]. The SGBP provides
free primary care for the entire population and referral care
against a flat co-payment for the insured population. With
help of the SGBP, access to health care has significantly im-
proved in the last years [33]. Jakab et al. [35] reported re-
sults of a survey in 2009 stating that the proportion of
people needing but not seeking care dropped from 11 % in
2000 to 4 % in 2009. Despite the fact that insurance is
mandatory in principle, a World Bank case study in 2013
found that about 30 % of the population remain uninsured
in practice [34]. For the uninsured, the level of co-
payments is almost twice as high as for the insured [34].
However, there are exemptions from co-payments for vul-
nerable populations, such as children under five, pensioners
above 75 years of age, disabled people, etc. Certain medical
conditions are also exempt from co-payments including
diseases that require high use of health services or for infec-
tious diseases. Type 1 and 2 Diabetes are exempt from co-
payments due to the high required use of health services
and TB is exempt due on its infectious nature [34]. While
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OOP have declined from 2001 to 2007, the remaining eco-
nomic burden of health payments is still considered to be
significant [33]. In addition to formal co-payments, a report
in 2012 extrapolated that informal payments for meals,
medicines, sundries and payments to health workers are
made at inpatient level and estimated the funding gap of
the SGBP to be at 34.8 % [36]. This underfunding suggests
a high rise of OOP to meet the funding gap if providers are
not able reclaim expenses from the state.
A households’ choice of strategy for coping with health
expenditure can have a sizeable impact on the creation
or prevention of catastrophic health spending [1]. Identi-
fying patterns in coping strategies and determinants of
the selection of strategies can help both in understand-
ing the financial context of affected households and
tailoring social protection mechanisms accordingly. In
Kyrgyzstan, research on coping strategies with OOP is
not yet available and their impact on financial protec-
tion, while there is evidence that the funding gap of the
SGBP requires ongoing reliance on OOP. Focusing on
TB, Diabetes and co-affected patients allows us to com-
pare variations in the economic burden of care seeking,
and the choice of coping strategies to bridge state fund-
ing gaps. This paper aims to explore the economic
burden and financial coping strategies of households af-
fected by Diabetes, TB and co-prevalence. Our study
adds to evidence of the effects of recent political reforms
in Kyrgyzstan and contributes to existing research on
households’ strategies of coping with economic burden
by introducing the double burden of two merging
diseases in a lower-middle income country.
Methods
Study design and data
This study uses data collected from a cross-sectional
survey administered in 2010 as part of a larger study
combining quantitative patient information and qualita-
tive caregiver information to understand and improve
the management of Diabetes and TB in Bishkek,
Kyrgyzstan. Patient data was collected using an adapted
questionnaire originally used to collect data on TB care
seeking in Cape Town, South Africa [37]. The question-
naire was translated from English to Russian and then
back-translated to ensure accuracy and coherence. The
english version of the questionnaire can be found in
Additional file 1. Exit interviews were conducted with
309 adult patients, and administered by experienced
local health systems researchers at four health facilities
which were most likely to provide care for Diabetes and
TB patients, the primary and secondary care facilities for
Bishkek (City Endocrinology Dispensary and the City TB
Hospital) and the tertiary facilities, which receive re-
ferred patients from all of Kyrgyzstan (the Endocrinology
Department of the National Hospital and the National
TB Centre). Diabetes patients are interviewed in dis-
pensaries and hospitals to include both outpatient
and inpatient care, while TB patients are interviewed
in the two hospitals which are most frequented. Eth-
ical clearance was obtained from University College
London (Project 0025/001). This data collection was part
of the project “Diabetics in Kyrgyzstan”, which was also
approved locally by the Committee on bioethics under the
Ministry of Health of Kyrgyzstan. All adult patients in the
waiting room on a given day were invited to participate in
the survey after receiving their treatment and giving writ-
ten informed consent. Interviews were on consecutive
days, starting from 3 September 2010 and continuing until
the sample size was achieved on 1 November 2010. Each
interview lasted approximately one hour. A simple quota
was used, resulting in a final sample of 138 patients with
Diabetes (either Type 1 or Type 2), 139 patients with TB,
and 32 patients with both illnesses.
The survey collected data on health expenditure (such
as direct medical and non-medical costs, formal and
informal treatment costs), socio-economic status (such
as age, gender, education level, employment status, and
household size) and financial coping strategies of pa-
tients (income and savings, social welfare and donations,
support from social networks, borrowing money or sell-
ing household assets). Education was measured in levels
of completed schooling (primary, secondary, tertiary).
Employment status was categorised as: being out of
work (unemployed or not able to work due to health is-
sues), working in an informal arrangement (subsistence
farming, self-employment or housekeeping), being for-
mally employed (public or private sector) or retired (in
retirement or pensioner).
The patient survey included specific information about
household income and health expenditure in the na-
tional currency, Kyrgyz Som (KGS). The exchange rate
was 46.14 KGS to 1.00 USD in 2011 [38]. Health ex-
penditure included three components: the cost of travel
to the health facility, informal payments made during
the hospital visit, and all formal payments incurred during
the visit including medicines, diagnostic tests, doctors’
fees, etc. Data were collected as aggregates for these com-
ponents for the most recent overnight admission, observa-
tion or emergency room visit and outpatient visit. Patients
were also asked for the reason for visiting to select only
those visits related to Diabetes and TB. These cost com-
ponents were then multiplied by the number of reported
visits in the last 90 days, to get an estimate of health
expenditure over this time span, while reducing the risk of
recall bias. Health facility visits are compared for both
single diseases and the co-prevalence.
Capacity to pay (CTP) was approximated by effective
income [2, 39]. Effective income represents household
income after subsistence needs are met. In urban
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settings, such as Bishkek, this effective income is often
used to calculate CTP [2, 40, 41]. To reflect economies
of scale in households with more members, household
income was transformed into equivalence income. This
was done by dividing household income by household
size to the power of 0.56. This equivalence scale had
been empirically derived from a multi-country regression
of household survey data from 59 countries [2, 40].
Minimum food expenditure was subtracted from equiva-
lence income and the remainder used as a measure of
CTP for health expenditure and a proxy for poverty risk
[40]. The average minimum food expenditure was
derived from a World Bank calculation based on the
Kyrgyzstan Integrated Households survey 2010 [42].
A commonly used measure of catastrophic health ex-
penditure is to estimate health expenditure proportional
to CTP. When using the CTP approach, a threshold of
40 % is commonly used [2]. If health expenditure ex-
ceeds the threshold and more than 40 % of the house-
hold’s CTP is being spent on health, a catastrophic
impact on the household may be expected [2]. The cata-
strophic payment method was chosen over the measure-
ment of impoverishment. The impoverishment approach
measures if patients drop below a poverty line after
health spending. Measuring impoverishment is however
dependent on an agreed poverty line. While a national
poverty line is available in Kyrgyzstan, a World Bank
report in 2011 [26] found that this national poverty line
is not representative of the actual subsistence level.
The selection and definition of coping strategies, is
adopted from the analytical framework developed by
McIntyre et al. [7]. To better represent the post-
communist context of Kyrgyzstan a coping strategy called
‘social welfare support and donations’ is added. Addition-
ally, social networks, such as family and friends, are in-
cluded in this analysis and represent informal social
protection mechanisms, as described by Russell [1]. As
such, the complete list of coping strategies included in this
study is as follows: income or savings, social welfare sup-
port or donations from employers or agencies; support
from social networks like friends and family; borrow
money; and raise money by selling assets. Patients
were asked if they used these strategies for coping
with the health care spending experienced in their
health care seeking in the last 90 days, but could also
indicate that they had used other coping strategies
not listed in the response options.
Coarsened exact matching
Comparing catastrophic health spending and coping
strategies within the three patient groups without control-
ling for confounding by differences in the socio-economic
status can result in overestimation of the effect of the
disease or co-prevalence. Matching the patient groups
according to their different socio-economic statuses helps
identify the unbiased effect of the disease on financial cop-
ing strategies and the occurrence of catastrophic health
spending. Nonparametric matching, such as CEM, allows
reducing these imbalances. While the regression models
still need to control for the socio-economic imbalances,
the model dependence is much lower than without
matching [43]. Multilevel matching is a very common
technique for the analysis of observational data and has
been employed in many recent studies analysing the
economic burden of disease [44–47]. Coarsened Exact
Matching (CEM) was used here to account for the socio-
economic differences in the patient cohorts.
CEM aims at finding exact matches, but interprets
“exact” as identical within a coarsened range of similar
covariates. CEM finds categories of similar covariates
based on distributions or intuitive division and matches
exactly within these categories [47, 48]. The detailed
methodology behind CEM can be read elsewhere [49,
50]. CEM has advantages over other matching algo-
rithms like propensity score matching and exact match-
ing, because it allows for the matching of groups with
unequal numbers of observations and allows a degree of
imprecision in the matching [47, 51]. This allows match-
ing even when observations are not precisely exact, as
long as they can be coarsened into similar categories.
While CEM was originally designed to match one
treated group to a untreated control group, it allows
matching of multi-level treatment [43, 49].
In this study, CEM was used to match observations
in the three patient groups, Diabetes, TB and co-
prevalence. CEM was used here to control confound-
ing by differences in the socio-economic background
of patients affected by the two diseases or co-affected.
The matching variables were: 1) gender, 2) age in
years, 3) education level, 4) employment status and 5)
equivalence income to control for differences in the
capacity to pay, adjusted for household size.
Data analysis
Data were analysed using, version R 3.0.2. In the descrip-
tive statistics, all mean calculations include 95 % confi-
dence intervals. For variables with skewed distributions,
such as income and expenditure, we include their me-
dians. Item non-response was checked and found to be
highest for household income (5.5 %) and employment
status (5.1 %). Household income and employment were
analysed for non-response bias in relation to other
socio-economic variables such as education, age, house-
hold size and gender. Non-response bias could be ruled
out and list-wise deletion was used in the analyses.
Regression models were used to analyse the associ-
ation between socio-economic background and coping
strategies. For each coping strategy, a logit model was
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conducted using the GLM function with a binomial logit
link in R. The socio economic variables used in these
models (as independent variables) were: gender, age,
education, employment and equivalence income in
tertiles1.
Odds ratios were calculated to compare the likelihood
of spending money on health care, engaging in cata-
strophic health spending and coping strategies between
the three patient groups. Three patient group variables
were generated (TB vs Diabetes, Co-affected vs Diabetes,
Co-affected vs TB) to allow pairwise subgroup compari-
son. The odds ratios were determined with regression
models for binary categorical variables using generalised
linear models with logistic distribution functions i.e.
logistic regressions [52]. As pointed out earlier, matching
only reduces the imbalance between the patient groups,
but does not completely eliminate it. Thus the regression
models should include all covariates of the original, un-
matched model [43, 49]. The regression models thus
control for the covariates: 1) gender, 2) age in years, 3)
education level, 4) employment status and 5) equivalence
income. All odds ratios were estimated for matched and
unmatched observations to allow a comparison of the as-
sociation of the patient groups alone and the imbalanced
association of patient group plus socio-economic back-
ground. While the models of the unmatched regressions
produce estimates of the combined association of disease
and socio-economic status, the logistic regressions of the
matched observations, shows associations of the disease
alone. All regression models were tested for influential
outliers using Bonferroni statistics and influence index
plots from the R package CAR, version 2.0-25. From the
same R package, variance inflation factors were used to
test multi-collinearity in all regression models.
Results
Differences in patient profile
Table 1 presents summary statistics of the main variables
included in the analysis. On average, Diabetes patients are
55 years old, while TB patients are 30 years old (p < 0.001).
Co-affected patients are approximately the same age
(54 years) as the Diabetes patients. While TB patients have
an equal gender ratio, Diabetes patients are mostly female
(70 %) and co-affected patients are mostly male (63 %). Al-
most all patients have completed secondary school. The
only differences are in the number of patients with com-
pleted tertiary education; while 54 % of Diabetes patients
and 61 % of co-affected patients have completed tertiary
education, only 31 % of TB patients have the same level of
education. Half of Diabetes patients are retired, while
61 % of TB patients are in informal or formal employ-
ment. While co-affected patients are in the age range of
Diabetes patients, they are only half as likely to be retired,
but more than twice as likely to earn money in informal
arrangements. TB patients are younger and accordingly,
more likely to be in paid work than Diabetes patients. Al-
though co-affected patients are the same age as Diabetes
patients, they do not use pensions as often. Instead of pen-
sions, co-affected patients earn money in informal
arrangements.
Equivalence income is highest in TB patients with 4704
KGS (106 USD), but this is not significantly higher (p =
0.183) than in Diabetes patients with 3683 KGS (83 USD).
Co-affected patients have the lowest equivalence income
with 2393 KGS (52 USD) and are significantly poorer
than Diabetes (p = 0.008) and TB patients (p = 0.004).
Figure 1 illustrates the differences in number of visits
in matched observations. The mean number of inpatient
admissions is around 1 and mean visits to the emergency
room are around 0 for all patient groups. There are,
however, differences in the number of outpatient visits
and visits to collect medication. Diabetes and co-affected
patients have a mean of 3 and 4 visits to outpatient facil-
ities respectively, while TB patients only visit the out-
patient facility once a month. Diabetes and co-affected
patients need on average 2 visits per month to collect
medication, while TB patients have on average 0 visits to
collect medication. Significance tests prove that the dif-
ferences between TB and Diabetes patients, as well as
the differences between TB and co-affected patients, are
significant. There is no significant difference between
Diabetes and co-affected patients. In outpatient and
medication collection visits, it becomes apparent that
the co-affected patients face the double burden of Dia-
betes care and TB care, with the number of visits being
exactly the sum of the other single disease patient
groups.
The analysis of health expenditure in Table 1 shows
that health expenditure is highest for Diabetes patients
and lowest for TB patients. The medians in Table 1,
illustrate however, that means comparison might not be
appropriate, since there is a substantial number of pa-
tients who did not face any health expenditure in the
last 90 days, despite using health services. From Table 5,
it can be seen that Diabetes patients are significantly
more likely to spend money for health care than TB pa-
tients and this finding is consistent after matching the
observations for socio-economic status. Co-affected pa-
tients are in the middle between the single disease
groups with a higher likelihood to face OOP than TB
patients, but a smaller likelihood than Diabetes patients.
Informal payments in hospitals and travel cost to total
health expenditure can further be distinguished from co-
payments for medication due to underfunding in the
SGBP. Informal payments for outpatient care were not
collected, which clearly limits this study with respect to
the analysis of informal payments. In hospital settings,
this study shows that all patient groups have median
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Table 1 Descriptive statistics by patient group
Variable Description All patients Only Diabetes Only TB Co-affected
Observations N 309 138 139 32
Age Mean 43.67 54.68 30.28 53.91
(95 % CI) (41.71 : 45.64) (52.46 : 56.90) (28.14 : 32.43) (50 : 57.82)
Gender (%) Female 58.06 70.29 50.36 37.50
Male 41.94 29.71 49.64 62.50
Education (%) No schooling 0.99 1.45 0.72 0.00
Primary 2.96 2.90 2.88 3.12
Secondary 50.66 39.86 64.75 28.12
Tertiary 45.39 54.35 30.22 62.5
Employment (%) Unemployed 21.77 16.67 24.46 21.88
Informal 30.61 19.57 35.97 40.62
Formal 18.37 13.04 23.74 6.25
Retired 29.25 50.00 5.76 28.12
Household size Mean 3.84 3.40 4.13 4.41
(95 % CI) (3.61 : 4.07) (3.03 : 3.77) (3.81 : 4.45) (3.73 : 5.08)
Household income in KGS Median 4500 3841 5000 4000
Mean 7559 6562 9190 5097
(95 % CI) (6208 : 8910) (5258 : 7866) (6455 : 11925) (3467 : 6726)
Equivalence income in KGSa Median 2199 2595 2702 1833
Mean 3989 3683 4704 2393
(95 % CI) (3288 : 4691) (3023 : 4343) (3273 : 6135) (1602 : 3184)
Total health expenditure in KGS Median 22 126 0 0
Mean 404 635 177 366
(95 % CI) (280 : 528) (378 : 891) (104 : 249) (59 : 672)
as informal payments in hospitals in KGS Median 0 0 0 0
Mean 55 (13 %) 0 (0 %) 109 (61 %) 63 (17 %)
as travel cost in KGS Median 0 0 0 0
Mean 140 (36 %) 254 (40 %) 49 (27 %) 43 (11 %)
Health spending of CTPb (%) Median 1.19 6.18 0.00 3.12
Mean 40.70 71.96 11.06 31.75
(95 % CI) (11: 70) (10: 134) (4: 18) (-4 : 68)
Visits to collect medication in the last 90 days (N) Mean 1.55 1.80 0.94 3.22
(95 % CI) (1.19 : 1.92) (1.58 : 2.01) (0.20 : 1.68) (2.06 : 4.38)
Outpatient visits in the last 90 days (N) Mean 2.28 3.16 1.07 3.81
(95 % CI) (2.03 : 2.54) (2.77 : 3.55) (0.86 : 1.27) (2.73 : 4.89)
ER visits in the last 90 days (N) Mean 0.15 0.11 0.17 0.19
(95 % CI) (0.09 : 0.20) (0.02 : 0.21) (0.09 : 0.24) (-0.01 : 0.39)
Inpatient admissions in the last 90 days (N) Mean 0.98 0.83 1.13 0.97
(95 % CI) (0.88 : 1.07) (0.66 : 1.00) (1.02 : 1.23) (0.81 : 1.12)
Number of coping strategies Mean 1.80 1.90 1.73 1.66
95 % C.I. (1.69 : 1.90) (1.76 : 2.04) (1.56 : 1.91) (1.32 : 1.99)
by income or savings N 208 77 106 24
by social welfare or donations N 109 72 30 7
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spending for informal payments of zero. Only few
participants, all among TB or co-affected patients, re-
ported to have informal payments. Similarly, travel
spending was reported zero by most of participants,
but for some patients getting to the health facility
can be costly. This is more often the case for
Diabetes patients with a mean spending of 254 KGS.
TB and co-affected patients have mean spending of
49 KGS and 43 KGS. The remaining health spending
can be seen as co-payments within the SGBP for
medicines, diagnostic tests, consultation and others.
Differences in coping strategy users
After demonstrating the higher economic burden for
Diabetes and co-affected patients, the focus of this section
of analysis is on the financial strategies for coping with the
economic burden of care. Table 2 shows the number of
coping strategies a patient or her/his household uses and
Table 1 Descriptive statistics by patient group (Continued)
by social networks N 173 78 77 18
by borrowing money N 31 15 13 3
by selling assets N 36 20 15 1
aKGS = Kyrgyz Som: US$ 1.00 = KGS 46.14 (at average 2011 exchange rate)
bCapacity to pay (CTP) is defined as equivalence income reduced by minimum food expenditure
Fig. 1 Box plot for health facility visits, matched observations
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the percentages of patients using a specific strategy for
their last care seeking event. 208 patients used income or
savings, 173 use social welfare and donations, 109 use sup-
port from social networks, 36 had to sell household assets
and 31 borrowed money. Among the 208 households
using income or savings, 34 % use this as their only coping
strategy. Among the 173 households using social net-
works, 23 % use this strategy as their only financing
source. Table 3 shows that social network is used most of
all strategies as an additional funding source. Social
welfare or donations are rarely used as a single strategy.
Borrowing money, selling assets, donations and social wel-
fare are also much more likely to be used in combination
with other strategies. Borrowing money is combined most
often with at least two or three additional strategies.
Additional regression analyses show that the socio-
economic background influences the decision which a
patient makes regarding what coping strategy to use.
Five multivariate regression models were conducted to
investigate association with socio-economic background
variables for each of the five coping strategies. Table 4
shows significant association between employment status,
age and equivalence income. Knowing that the socio-
economic background varies within the three patient
groups and knowing that socio-economic background is
also associated with coping, raise this question whether
choice of coping strategy is associated with disease or with
socio-economic context of the patient arises. The next
section compares coping in patient groups with balanced
and imbalanced socio-economics and thus allows differen-
tiating the association between patient groups and coping
strategy.
Catastrophic health expenditure and coping strategies
Using CEM, 175 of 310 observations could be matched,
reducing the imbalance score of L1 by 88 %. Table 5
shows the odds ratios for matched and unmatched ob-
servations for three patient groups. While the models of
the unmatched regressions produce estimates of the
combined or imbalanced association of disease and
socio-economic status, the logistic regressions of the
matched observations, find the association with the dis-
ease alone. The odds ratio in the unmatched observa-
tions show four significant results: 1) TB patients are
more likely to use income or savings than Diabetes pa-
tients, 2) Diabetes patients are more likely to use social
welfare or donations than TB patients, 3) co-affected pa-
tients are less likely to use social welfare or donations
than Diabetes patients and 4) co-affected patients are
more likely to face catastrophic health spending than TB
patients. When using the CEM approach to match the
observations for socio-economic status, the logistic
regression models show three significant results: 1) TB
patients are less likely to engage in catastrophic health
spending than Diabetes patients, 2) Diabetes patients are
more likely to use social welfare or donations than TB
patients and 3) co-affected patients are less likely to use
social welfare or donations than Diabetes patients.
Discussion
Diabetes and TB affect patients with different socio-
economic and demographic characteristics. In this study,
Diabetes patients are older and more likely to be female.
They are more likely to have completed higher levels of
education and to be pensioners. TB patients on the
Table 2 Coping strategies by number of strategies used simultaneously
Number of coping
strategies used
All observations Income or
savings
Social welfare
or donations
Social
networks
Borrowing
money
Selling
assets
0 12 4 % - - - - - - - - - -
1 122 40 % 71 34 % 10 9 % 39 23 % 0 0 % 3 8 %
2 109 35 % 82 39 % 44 40 % 72 42 % 5 16 % 15 42 %
3 50 16 % 41 20 % 40 37 % 46 27 % 10 32 % 13 36 %
4 14 5 % 12 6 % 13 12 % 14 8 % 14 45 % 3 8 %
5 2 1 % 2 1 % 2 2 % 2 1 % 2 6 % 2 6 %
total 309 100 % 208 100 % 109 100 % 173 100 % 31 100 % 36 100 %
Table 3 Combinations of coping strategies, by number of patients using at least two strategies, with patient group
Number of patients using
at least two strategies
Income or savings
(Dia,TB,Co)
Social welfare or
donations (Dia,TB,Co)
Social networks
(Dia,TB,Co)
Borrowing money
(Dia,TB,Co)
Selling assets
(Dia,TB,Co)
Income or savings 70 (39,24,7) 98 (30,57,11) 20 (7,11,2) 20 (7,12,1)
Social welfare or donations 70 (39,24,7) 71 (38,28,5) 20 (8,10,2) 10 (8,2,0)
Social networks 98 (30,57,11) 71 (38,28,5) 26 (12,11,3) 19 (11,8,0)
Borrowing money 20 (7,11,2) 20 (8,10,2) 26 (12,11,3) 9 (6,3,0)
Selling assets 20 (7,12,1) 10 (8,2,0) 19 (11,8,0) 9 (6,3,0)
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Table 4 Regression results, associations between coping strategy and variables of socioeconomic background
Income & savings Social Welfare & Donations Social Networks Borrowing money Selling assets
Coeff. (S.E.) Coeff. (S.E.) Coeff. (S.E.) Coeff. (S.E.) Coeff. (S.E.)
(Intercept) 16.69 -1.16 15.22 -15.13 -16.48
(994.52) (1.51) (992.70) (1018.94) (1006.01)
Age: for each year -0.03 ** -0.00 0.01 -0.00 0.03 *
(0.01) (0.01) (0.01) (0.02) (0.02)
Gender: female vs male -0.47 0.10 0.43 -0.01 0.31
(0.31) (0.31) (0.27) (0.45) (0.44)
Education: compl. primary vs no schooling -14.85 1.85 -12.97 16.47 14.58
(994.52) (1.73) (992.71) (1018.94) (1006.01)
Education: compl. secondary vs no schooling -15.30 0.30 -14.58 13.85 13.60
(994.52) (1.45) (992.70) (1018.94) (1006.01)
Education: compl. tertiary vs no schooling -15.31 -0.27 -15.04 14.11 12.39
(994.52) (1.45) (992.70) (1018.94) (1006.01)
Employment: informal vs unemployed 1.20 *** -1.05 ** -1.01 *** -1.92 *** -0.23
(0.41) (0.43) (0.38) (0.70) (0.70)
Employment: formal vs unemployed 1.01 ** -0.66 -1.30 *** -0.73 0.70
(0.46) (0.45) (0.43) (0.60) (0.62)
Employment: retired vs unemployed 0.50 1.37 *** -1.08 ** -0.52 -0.33
(0.46) (0.48) (0.46) (0.65) (0.71)
Equivalence income: second tertile vs first tertile 0.16 0.40 -0.16 -0.66 0.60
(0.34) (0.37) (0.32) (0.57) (0.47)
Equivalence income: third tertile vs first tertile 0.41 0.93 * 0.25 -0.05 -0.23
(0.36) (0.37) (0.33) (0.50) (0.55)
AIC 323.48 312.77 364.85 184.11 200.28
BIC 362.85 352.23 404.36 223.57 239.74
Log Likelihood -150.74 -145.39 -171.43 -81.06 -89.14
Deviance 301.48 290.77 342.85 162.11 178.28
Num. obs. 265 267 268 267 267
***p < 0.01, **p < 0.05, *p <0.1
Table 5 Odds ratio of spending money for health care, engaging in catastrophic health spending and financial coping, matched
and unmatched
Unmatched (n = 310) Matched (n = 175)
TB vs Diabetes Co-affected
vs Diabetes
Co-affected
vs TB
TB vs Diabetes Co-affected
vs Diabetes
Co-affected
vs TB
OR (S.E.) OR (S.E.) OR (S.E.) OR (S.E.) OR (S.E.) OR (S.E.)
Spending money on health care 0.41 (1.39)*** 0.61 (1.60) 1.24 (1.65) 0.33 (1.54)** 0.48 (1.77) 1.18 (1.74)
Catastrophic health spending 0.65 (1.41) 1.68 (2.04) 3.82 (2.01)* 0.24 (2.12)* 2.03 (2.80) 3.44 (3.13)
Coping Strategies:
Income or savings 2.91 (1.43)*** 1.30 (1.70) 0.77 (1.83) 1.92 (1.57) 1.15 (1.84) 0.91 (1.85)
Social welfare or donations 0.42 (1.43)** 0.19 (1.85)*** 1.97 (2.11) 0.18 (1.75)*** 0.26 (2.05)* 3.26 (2.44)
Social Networks 0.88 (1.39) 1.19 (1.62) 0.93 (1.73) 1.16 (1.51) 0.98 (1.73) 1.03 (1.79)
Borrowing money 0.90 (1.67) 0.75 (2.09) 3.09 (2.65) 0.41 (2.62) 1.07 (2.54) 6.04 (3.60)
Selling assets 0.53 (1.62) 0.29 (3.00) 0.28 (3.21) 0.60 (1.88) 0.24 (3.13) 0.25 (3.35)
*** p < 0.01, ** p < 0.05, * p < 0.1
Arnold et al. BMC Health Services Research  (2016) 16:118 Page 9 of 13
other hand are younger and have completed fewer levels
of education. They are more likely to work, but as likely
female as male. Co-affected patients are similar to Dia-
betes patients in age and education, but are more likely
to be male and are less likely to live off pension income
but more likely to earn money in informal arrangements.
This is similar to case studies by Deshmukh, Shaw [53]
and Pérez-Guzmán et al. [54] finding male dominance in
co-affected patients. Additionally, co-affected patients
have significantly lower equivalence income, due to
lower household income in bigger households. Accord-
ingly, co-infection affects Diabetes patients with low
socio-economic status. This is supported by other stud-
ies identifying socio-economic factors as main drivers of
TB infections [55–58].
The management of Diabetes and Tuberculosis in
Kyrgyzstan is organised in vertical systems [59]. Vertical
systems carry the risk of multiplying the burden of care-
seeking experienced by patients with more than one
disorder [60]. This was one of the reasons why the WHO
and the International Union Against Tuberculosis and
Lung Diseases advised coordinated management of the
diseases in their collaborative framework [55, 60]. TB care
receives support from international donors [61], while
Diabetes care is financed solely through national budgets.
In the face of the high rates of MDR-TB in Kyrgyzstan
and the additional funding required to meet these chal-
lenges [62], government commitment to increase the
SGBP funding is crucial. The call for more funding is even
more urgent knowing that OOP still play an important
role, especially for Diabetes care.
In this study, we find that the financial burden of care
seeking is significantly greater in patients affected by Dia-
betes than TB and significantly greater for co-affected pa-
tients than TB patients due to their lower socio-economic
status. The burden thus is regressive for these co-affected
patients. As Skordis-Worrall et al. [63] point out, in
Kyrgyzstan TB care is provided on inpatient basis, usually
an admission for two to three months, followed by out-
patient treatment for four months. Diabetes is mainly
treated at outpatient level, but can also include inpatient
admission. Diabetes care creates a bigger economic burden
on patients and their households than TB care by demand-
ing frequent outpatient visits, visits to collect medication
and by the fact that insulin that should be free under the
SGBP is often not unavailable and needs to be purchased
from private pharmacies. The economic burden of co-
prevalence is then especially high, since Diabetes and TB
care are not offered in the same facilities, but require pa-
tients to visit both service providers. Since both informal
payments and travel cost were only reported by few pa-
tients, therefore, it can be concluded that the main driver
of the economic burden are payments for health facility
visits and payments for unavailable medication.
As mentioned, TB is treated in inpatient care in
Kyrgyzstan in the urban setting of Bishkek, while Dia-
betes care demands frequent visits to outpatient facilities
or dispensaries to collect medication. This can affect the
measurement of the economic burden of TB care in
Kyrgyzstan compared to other countries where TB care
is provided in communities. One can speculate that
hospital-based care is likely to have smaller formal, dir-
ect costs, but higher indirect and opportunity cost for
patients than community-based care. Considering this,
one would expect that informal and travel cost to be
higher for TB patients. While there are some TB patients
who experience high informal cost, this is not true for
every patient. Khan et al. [64] found that in Pakistan,
community-based care has smaller opportunity cost than
hospital-based care and overall smaller patient cost. This
finding was also supported by Okello et al. [65] in Uganda
and Sinanovic et al. [66] in South Africa who found that
rural community-based TB care is more cost-effective
than hospital-based care and the overall economic burden
for patients is smaller. Scale up of outpatient based DOTS
programmes all over the country could be a method to
reduce the economic burden for TB and co-affected
patients.
The financing strategies used for coping with the eco-
nomic burden can indicate how well the social protection
system in Kyrgyzstan functions and whether adjustments
are necessary. The primary income source is used domin-
antly as the main financial coping strategy. Social network
support is often used as secondary or additional financial
source. The primary income source is most often work in-
come for TB patients, because of their relatively young age,
and pensions for Diabetes patients. Co-affected patients
despite being the same age as Diabetes patients, use pen-
sions less often. When socio-economic differences are bal-
anced between Diabetes and TB patients, TB patients are
significantly less likely to experience catastrophic health
spending. If unmatched observations are used, the associ-
ation is however not significant. One possible interpretation
is that the socio-economic context of Diabetes patients
actually protects them better than TB patients. The main
difference in the socio-economic background naturally is
the older age and the access to social welfare support, such
as pensions, which provide income even in time of illness.
The matching also shows that the association between co-
prevalence and catastrophic health spending is due to the
differences in socio-economic context. Co-affected patients
are much more likely to experience catastrophic health
spending than TB patients, who are younger and from a
higher socio-economic background. When those socio-
economic imbalances are controlled for by matching, the
association loses its significance.
Coping with the health burden poses a range of chal-
lenges and not all households have the capacity to avoid
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catastrophic health expenditure. These data have shown
that, in this context, households in the three patient groups
have different socio-economic profiles and their choice of
coping strategy depends on their background. Reliable
sources of money, such as income from salaries and pen-
sions are used very frequently, but are often topped up with
assistance from friends or family. These social networks
also play an important role as a social protection mechan-
ism in the absence of other income sources. This finding
supports other studies finding that informal loans from
family, friends or employer [67, 68] are very important for
health financing. Coping strategies that draw on the house-
hold’s future income or capital stock are not used
frequently in this context. While other studies found that
loans from money lenders [14, 17] play a very important
role in the financing of health expenditure and the depend-
ency on loans increases with decreasing wealth [11], here
borrowing money is used only rarely and is linked to
unemployment rather than low income.
Limitations
This study has a number of limitations which should be
acknowledged. Firstly, there is no control group in the
sample, the level of co-payments for other diseases is
accordingly not available. It could be possible that the co-
payments experienced by Diabetes or TB patients are thus
not significantly different than in the general population.
Secondly, this study did not include some confounding
variables, such as HIV status, if Diabetes was Type 1
or Type 2 or MDR-TB. HIV is, however, very rare in
Kyrgyzstan with a prevalence of under one percent [69];
Diabetes patients were all adults and had an average age
which speaks more for Type 2 than for Type 1 diabetes.
Thirdly, the small sample size (in particular co-affected
patients) limits this study’s power in the analysis of
the co-affected patient group.
Fourthly, the extent of economic burden and cata-
strophic health spending might be underestimated in
comparison to the general population, since patient
interviews were held at health facilities. Patients who
chose to cope with the economic burden by not seeking
treatment are thus excluded in this study sample. In
addition, it should be noted that service provision should
be free for Diabetes and TB patients under the SGBP and
it is possible that the participant in this study might have
not shared all information in the exit interview in the
waiting rooms. It cannot be ruled out that not all informa-
tion about health care spending was reported. This could
mean that the true economic burden and the level of
catastrophic health spending are underestimated.
Lastly, recent research on the capacity to pay method-
ology suggested using a larger basket of consumption good
than food expenditure to reflect household basic consump-
tion in a more realistic way. In absence of a new estimation
of subsistence spending, the World Bank estimate based on
food expenditure was used. However, capacity to pay may
further be overestimated in this study and thus catastrophic
health spending can be further underestimated [70].
Conclusion
The health sector in Kyrgyzstan aims to offer treatment
for Diabetes and TB free at the point of use, through the
SGBP. While studies have shown that the implementa-
tion of the SGBP has improved access to health services
and equity in care by protecting patients from some por-
tion of the financial burden [33, 71], other studies have
challenged this finding and claimed that OOPs are still
existent and continue to impose a significant economic
burden on affected households [34, 36].
This study provides evidence that Diabetes and co-
affected households face significant financial burden. Due
to the chronic nature of Diabetes, this economic burden
has long-term implications for the economic survival of
households. They do not appear to be fully protected from
that burden by provisions from the State. As such, in order
to continue reducing the dependence on OOP, and the
economic burden of ill health faced by affected households,
the funding gap in the SGBP needs closer attention. This
study shows that OOP are greater for Diabetes affected pa-
tients and co-affected patients than for TB patients. While
a previous study [36] attributed the funding gap in majority
to informal payments in hospitals, these payments were
not found to be very common in this study. This leads to
the conclusion that the funding gap in the SGBP and the
resulting co-payments for medication, tests and other sup-
plies impose the economic burden on households. The
funding of the SGBP needs to be improved in order to pro-
vide access to continuous free-of-charge health care and
continue reducing the OOP, especially for Diabetes patients
with low socio-economic status, outpatient care and lower
socio-economic households in general.
In the urban setting of Bishkek, pensions play an import-
ant role in coping with the economic burden of Diabetes.
For co-affected patients however, pensions are not suffi-
cient or available and thus additional income generation in
the informal sector is necessary. Co-affected patients are
not only challenged by their disease and socio-economic
status, but also by the structure of service provision. Since
TB and Diabetes services are not being offered in the same
facility, co-affected patients necessarily face the double bur-
den. Scaling up the DOTS and DOTS plus programme to
outpatient services within the Diabetes dispensaries can
help reducing the burden.
Endnotes
1Equivalence income tertiles were from 0 to 1,680
KGS, from 1,680 to 3,390 KGS and from 3,390 to
27,000 KGS.
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